Epidemien und Pandemien in der hausärztlichen Praxis

M. Eisele,H. Hansen,H. Wagner,E. von Leitner,N. Pohontsch,M. Scherer

DOI: https://doi.org/10.1007/s00103-014-1970-z

2014-05-10

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Abstract:

What problem does this paper attempt to address?

Electromechanical Relationship in Hypertrophic Cardiomyopathy

Xiaoping Lin,Hsin-Yueh Liang,Aurelio Pinheiro,Veronica Dimaano,Lars Sorensen,Miguel Aon,Larisa G. Tereshchenko,Yihan Chen,Meixiang Xiang,Theodore P. Abraham,M. Roselle Abraham

DOI: https://doi.org/10.1007/s12265-013-9481-0

2013-01-01

Journal of Cardiovascular Translational Research

Abstract:We examined whether there is a relationship between repolarization abnormalities on electrocardiography (EKG) and deformation abnormalities by echocardiography. Analysis of baseline EKGs and mechanical (echo-based deformation) changes was performed in 128 patients with a clinical diagnosis of hypertrophic cardiomyopathy (HCM). Patients with left ventricular hypertrophy (LVH) or repolarization abnormalities had higher septal thickness when compared to patients with normal EKG. Patients with EKG evidence of LVH or QT c prolongation had lower systolic velocity, systolic strain, systolic strain rate, late diastolic velocity, and late diastolic strain rate than patients with a normal EKG. Patients with strain pattern or ST depression/T-wave inversion had lower systolic velocity, systolic strain, systolic strain rate, early diastolic velocity, and late diastolic velocity when compared to patients with normal EKGs. LVH and repolarization abnormalities on surface EKG are markers of impaired systolic and diastolic mechanics in HCM.
Abstract 58: Modeling Pathogenesis in Familial Hypertrophic Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells

Feng Lan,Andrew Lee,Ping Liang,Enrique Navarrete,Li Wang,Han Leng,Veronica Sanchez,Michelle Yen,Yongming Wang,Patricia Nguyen,Ning Sun,Oscar Abilez,Richard Lewis,Yoshinori Yamaguchi,Euan Ashley,Donald Bers,Robert Robbins,Michael Longaker,Joseph Wu

DOI: https://doi.org/10.1161/res.111.suppl_1.a58

IF: 23.213

2012-01-01

Circulation Research

Abstract:Background: Hypertrophic cardiomyopathy (HCM) is a prevalent familial cardiac disorder linked to development of heart failure, arrhythmia, and sudden cardiac death. Molecular genetic studies have demonstrated HCM is caused by mutations in genes encoding for the cardiac sarcomere. However, the pathways by which sarcomeric mutations result in myocyte hypertrophy and contractile abnormalities are not well understood. Methods: We aimed to elucidate the molecular mechanisms underlying the development of HCM through the generation of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) from dermal fibroblasts of a 10 member family, five of whom carry a hereditary HCM missense mutation (Arg663His) in the MYH7 gene. Results: As compared to control iPSC-CMs derived from healthy family members, HCM iPSC-CMs exhibited enlarged cell size, increased atrial natriuretic factor (ANF) expression, nuclear translocation of nuclear factor of activated T-cells (NFAT), and aggravated contractile dysfunction in response to stimulation by β-adrenergic agonists. Interestingly, both video analysis of beating cells and whole cell patch clamping revealed arrhythmia in a significant portion of diseased iPSC-CMs at the single cell level. Ca 2+ imaging demonstrated elevated cytoplasmic Ca 2+ content and irregular transients in HCM iPSC-CMs prior to the onset of cellular hypertrophy, suggesting the HCM phenotype is triggered by dysfunction in Ca 2+ cycling. Treatment of irregular Ca 2+ homeostasis by the Ca 2+ channel blocker verapamil prevented development of cellular hypertrophy and arrhythmia. Conclusions: We hypothesize the cellular abnormalities observed in HCM iPSC-CMs are caused by deficiencies in Ca 2+ regulation. We anticipate our findings will elucidate the mechanisms underlying HCM development and identify novel targets for treatment of the disease.
Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography

George Joy,Luis R. Lopes,Matthew Webber,Alessandra M. Ardissino,James Wilson,Fiona Chan,Iain Pierce,Rebecca K. Hughes,Konstantinos Moschonas,Hunain Shiwani,Robert Jamieson,Paula P. Velazquez,Ramya Vijayakumar,Erica Dall’Armellina,Peter W. Macfarlane,Charlotte Manisty,Peter Kellman,Rhodri H. Davies,Maite Tome,Vladan Koncar,Xuyuan Tao,Christoph Guger,Yoram Rudy,Alun D. Hughes,Pier D. Lambiase,James C. Moon,Michele Orini,Gabriella Captur

DOI: https://doi.org/10.1016/j.jacc.2024.01.006

IF: 24

2024-02-01

Journal of the American College of Cardiology

Abstract:BACKGROUND: Ventricular arrhythmia in hypertrophic cardiomyopathy (HCM) relates to adverse structural change and genetic status. Cardiovascular magnetic resonance (CMR)-guided electrocardiographic imaging (ECGI) noninvasively maps cardiac structural and electrophysiological (EP) properties.OBJECTIVES: The purpose of this study was to establish whether in subclinical HCM (genotype [G]+ left ventricular hypertrophy [LVH]-), ECGI detects early EP abnormality, and in overt HCM, whether the EP substrate relates to genetic status (G+/G-LVH+) and structural phenotype.METHODS: This was a prospective 211-participant CMR-ECGI multicenter study of 70 G+LVH-, 104 LVH+ (51 G+/53 G-), and 37 healthy volunteers (HVs). Local activation time (AT), corrected repolarization time, corrected activation-recovery interval, spatial gradients (GAT/GRTc), and signal fractionation were derived from 1,000 epicardial sites per participant. Maximal wall thickness and scar burden were derived from CMR. A support vector machine was built to discriminate G+LVH- from HV and low-risk HCM from those with intermediate/high-risk score or nonsustained ventricular tachycardia.RESULTS: Compared with HV, subclinical HCM showed mean AT prolongation (P = 0.008) even with normal 12-lead electrocardiograms (ECGs) (P = 0.009), and repolarization was more spatially heterogenous (GRTc: P = 0.005) (23% had normal ECGs). Corrected activation-recovery interval was prolonged in overt vs subclinical HCM (P < 0.001). Mean AT was associated with maximal wall thickness; spatial conduction heterogeneity (GAT) and fractionation were associated with scar (all P < 0.05), and G+LVH+ had more fractionation than G-LVH+ (P = 0.002). The support vector machine discriminated subclinical HCM from HV (10-fold cross-validation accuracy 80% [95% CI: 73%-85%]) and identified patients at higher risk of sudden cardiac death (accuracy 82% [95% CI: 78%-86%]).CONCLUSIONS: In the absence of LVH or 12-lead ECG abnormalities, HCM sarcomere gene mutation carriers express an aberrant EP phenotype detected by ECGI. In overt HCM, abnormalities occur more severely with adverse structural change and positive genetic status.

cardiac & cardiovascular systems
Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells.

Feng Lan,Andrew S. Lee,Ping Liang,Veronica Sanchez-Freire,Patricia K. Nguyen,Li Wang,Leng Han,Michelle Yen,Yongming Wang,Ning Sun,Oscar J. Abilez,Shijun Hu,Antje D. Ebert,Enrique G. Navarrete,Chelsey S. Simmons,Matthew Wheeler,Beth Pruitt,Richard Lewis,Yoshinori Yamaguchi,Euan A. Ashley,Donald M. Bers,Robert C. Robbins,Michael T. Longaker,Joseph C. Wu

DOI: https://doi.org/10.1016/j.stem.2012.10.010

IF: 23.9

2013-01-01

Cell Stem Cell

Abstract:Familial hypertrophic cardiomyopathy (HCM) is a prevalent hereditary cardiac disorder linked to arrhythmia and sudden cardiac death. While the causes of HCM have been identified as genetic mutations in the cardiac sarcomere, the pathways by which sarcomeric mutations engender myocyte hypertrophy and electrophysiological abnormalities are not understood. To elucidate the mechanisms underlying HCM development, we generated patient-specific induced pluripotent stem cell cardiomyocytes (iPSC-CMs) from a ten-member family cohort carrying a hereditary HCM missense mutation (Arg663His) in the MYH7 gene. Diseased iPSC-CMs recapitulated numerous aspects of the HCM phenotype including cellular enlargement and contractile arrhythmia at the single-cell level. Calcium (Ca(2+)) imaging indicated dysregulation of Ca(2+) cycling and elevation in intracellular Ca(2+) ([Ca(2+)](i)) are central mechanisms for disease pathogenesis. Pharmacological restoration of Ca(2+) homeostasis prevented development of hypertrophy and electrophysiological irregularities. We anticipate that these findings will help elucidate the mechanisms underlying HCM development and identify novel therapies for the disease.
Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study

James A Coleman,Ruben Doste,Zakariye Ashkir,Raffaele Coppini,Rafael Sachetto,Hugh Watkins,Betty Raman,Alfonso Bueno-Orovio

DOI: https://doi.org/10.1093/cvr/cvae086

IF: 13.081

2024-04-23

Cardiovascular Research

Abstract:Aims Lethal arrhythmias in hypertrophic cardiomyopathy (HCM) are widely attributed to myocardial ischaemia and fibrosis. How these factors modulate arrhythmic risk remains largely unknown, especially as invasive mapping protocols are not routinely used in these patients. By leveraging multiscale digital-twin technologies, we aim to investigate ischaemic mechanisms of increased arrhythmic risk in HCM. Methods and Results Computational models of human HCM cardiomyocytes, tissue and ventricles were used to simulate outcomes of phase 1A acute myocardial ischaemia. Cellular response predictions were validated with patch-clamp studies of human HCM cardiomyocytes (n=12 cells, N=5 patients). Ventricular simulations were informed by typical distributions of subendocardial/transmural ischaemia as analysed in perfusion scans (N=28 patients). S1-S2 pacing protocols were used to quantify arrhythmic risk for scenarios in which regions of septal obstructive hypertrophy were affected by (i) ischaemia, (ii) ischaemia and impaired repolarisation, and (iii) ischaemia, impaired repolarisation, and diffuse fibrosis. HCM cardiomyocytes exhibited enhanced action potential and abnormal effective refractory period shortening to ischaemic insults. Analysis of c.a. 75,000 re-entry induction cases revealed that the abnormal HCM cellular response enabled establishment of arrhythmia at milder ischaemia than otherwise possible in healthy myocardium, due to larger refractoriness gradients that promoted conduction block. Arrhythmias were more easily sustained in transmural than subendocardial ischaemia. Mechanisms of ischaemia-fibrosis interaction were strongly electrophysiology dependent. Fibrosis enabled asymmetric re-entry patterns and break-up into sustained ventricular tachycardia. Conclusions HCM ventricles exhibited an increased risk to non-sustained and sustained re-entry, largely dominated by an impaired cellular response and deleterious interactions with the diffuse fibrotic substrate.

cardiac & cardiovascular systems
Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial, electrophysiology study inclusive approach

Petros Arsenos,Konstantinos A Gatzoulis,Dimitrios Tsiachris,Polychronis Dilaveris,Skevos Sideris,Ilias Sotiropoulos,Stefanos Archontakis,Christos-Konstantinos Antoniou,Athanasios Kordalis,Ioannis Skiadas,Konstantinos Toutouzas,Charalambos Vlachopoulos,Dimitrios Tousoulis,Konstantinos Tsioufis

DOI: https://doi.org/10.4330/wjc.v14.i3.139

2022-03-26

Abstract:Annual arrhythmic sudden cardiac death ranges from 0.6% to 4% in ischemic cardiomyopathy (ICM), 1% to 2% in non-ischemic cardiomyopathy (NICM), and 1% in hypertrophic cardiomyopathy (HCM). Towards a more effective arrhythmic risk stratification (ARS) we hereby present a two-step ARS with the usage of seven non-invasive risk factors: Late potentials presence (≥ 2/3 positive criteria), premature ventricular contractions (≥ 30/h), non-sustained ventricular tachycardia (≥ 1episode/24 h), abnormal heart rate turbulence (onset ≥ 0% and slope ≤ 2.5 ms) and reduced deceleration capacity (≤ 4.5 ms), abnormal T wave alternans (≥ 65μV), decreased heart rate variability (SDNN < 70ms), and prolonged QTc interval (> 440 ms in males and > 450 ms in females) which reflect the arrhythmogenic mechanisms for the selection of the intermediate arrhythmic risk patients in the first step. In the second step, these intermediate-risk patients undergo a programmed ventricular stimulation (PVS) for the detection of inducible, truly high-risk ICM and NICM patients, who will benefit from an implantable cardioverter defibrillator. For HCM patients, we also suggest the incorporation of the PVS either for the low HCM Risk-score patients or for the patients with one traditional risk factor in order to improve the inadequate sensitivity of the former and the low specificity of the latter.
Changing management of gallstone disease during pregnancy

Russell E. Glasgow,Brendan C. Visser,Hobart W. Harris,Marco G. Patti,S. Kilpatrick,S. J. Mulvihill

DOI: https://doi.org/10.1007/s004649900643

1998-03-01

Surgical Endoscopy

Abstract:
Hypersynchrony in sarcomeric hypertrophic cardiomyopathy: description and mechanistic approach using multimodal electro-mechanical non-invasive cartography (HSYNC study)

Patricia Réant,Guillaume Bonnet,Frédérique Dubé,Charles Massie,Amélie Reynaud,Matthieu Michaud,Josselin Duchateau,Stéphane Lafitte

DOI: https://doi.org/10.3389/fcvm.2024.1359657

IF: 3.6

2024-06-08

Frontiers in Cardiovascular Medicine

Abstract:Background: Little is known about left ventricular (LV) sequences of contraction and electrical activation in hypertrophic cardiomyopathy (HCM). A better understanding of the underlying relation between mechanical and electrical activation may allow the identification of predictive response criteria to right ventricular DDD pacing in obstructive patients. Objective: To describe LV mechanical and electrical activation sequences in HCM patients compared to controls. Materials and methods: We prospectively studied, in 40 HCM patients (20 obstructive and 20 non-obstructive) and 20 healthy controls: (1) mechanical activation using echocardiography at rest and cardiac magnetic resonance imaging, (2) electrical activation using 3-dimensional electrocardiographic mapping (ECM). Results: In echocardiography, healthy controls had a physiological apex-to-base delay (ABD) during contraction (23.8 ± 16.2 ms). Among the 40 HCM patients, 18 HCM patients presented a loss of this ABD (<10 ms, defining hypersynchrony) more frequently than controls (45% vs. 5%, p = 0.017). These patients had a lower LV end-diastolic volume (71.4 ± 9.7 ml/m 2 vs. 82.4 ± 14.8 ml/m 2 , p = 0.01), lower native T1 values (988 ± 32 ms vs. 1,028 ± 39 ms, p = 0.001) and tended to have lower LV mass (80.7 ± 23.7 g/m 2 vs. 94.5 ± 25.3 g/m 2 , p = 0.08) compared with HCM patients that had a physiological contraction sequence. There was no significant relation between ABD and LV outflow tract obstruction. While HCM patients with a physiological contraction sequence presented an ECM close to those encountered in controls, patients with a loss of ABD presented a particular pattern of ECM with the first potential more frequently occurring in the postero-basal region. Conclusion: The LV contraction sequence can be modified in HCM patients, with a loss of the physiological ABD, and is associated with smaller LV dimensions and a particular pattern of ECM. Further research is needed to determine whether this pattern is related to an electrical substrate or is the consequence of the hypertrophied heart's specific geometry. Clinical trial registration: ClinicalTrial.gov: NCT02559726.

cardiac & cardiovascular systems
Novel electric predictors of lethal arrhythmic event in patients with hypertrophic cardiomyopathy

J I Choi,J H Jeong,H D Kook,H S Lee,Y Y Choi,S R Kim,D H Cho,Y G Kim,M N Kim,J Shim,S M Park,Y H Kim

DOI: https://doi.org/10.1093/eurheartj/ehae666.670

IF: 39.3

2024-10-30

European Heart Journal

Abstract:Background Little is known regarding the association between electrical markers and lethal arrhythmic events (LAE) in patients with hypertrophic cardiomyopathy (HCM). This study aimed to identify the electrical predictors of LAE in adult patients with HCM. Methods This study was a retrospective analysis of patients with HCM at a single center from 1998 to 2021. LAE was defined as a composite outcome of (1) sustained ventricular arrhythmia, (2) aborted sudden cardiac death (SCD), (3) implantable cardioverter defibrillator (ICD) implantation, and (4) appropriate ICD shock. A 12-lead electrocardiography was performed at the time of diagnosis. Results A total of 611 patients with HCM were analyzed, and 48 (7.8%) experienced LAE. Patients who experienced LAE were diagnosed at a younger age and more frequently had history of ventricular arrhythmia, new-onset atrial fibrillation (AF) or non-sustained ventricular tachycardia. New-onset AF, an increase in the QTc interval, and the absence of massive LVH were associated with LAE risk. In addition to conventional markers of HCM Risk-SCD, consideration of the QTc interval and massive LVH on electrocardiography improved the prediction of LAE (area under curve 0.682 to 0.740). Further inclusion of new-onset AF, history of ventricular arrhythmia, HCM type, and left ventricular mass index improved the predictability to 0.867. Conclusion An increase in the QTc interval, the absence of a massive LVH pattern on electrocardiography (ECG), and new-onset AF were independently associated with an increased risk of LAE. Comprehensive stratification using electrical markers improves the prediction of LAE when combined with conventional markers.

cardiac & cardiovascular systems
Reduced connexin-43 expression, slow conduction and repolarisation dispersion in a model of hypertrophic cardiomyopathy

Seakcheng Lim,Melissa M Mangala,Mira Holliday,Henrietta Cserne Szappanos,Samantha Barratt-Ross,Serena Li,Jordan Thorpe,Whitney Liang,Ginell N Ranpura,Jamie I Vandenberg,Christopher Semsarian,Adam P Hill,Livia C Hool

DOI: https://doi.org/10.1242/dmm.050407

2024-08-01

Abstract:Hypertrophic cardiomyopathy (HCM) is an inherited heart muscle disease that is characterised by left ventricular wall thickening, cardiomyocyte disarray and fibrosis, and is associated with arrhythmias, heart failure and sudden death. However, it is unclear to what extent the electrophysiological disturbances that lead to sudden death occur secondary to structural changes in the myocardium or as a result of HCM cardiomyocyte electrophysiology. In this study, we used an induced pluripotent stem cell model of the R403Q variant in myosin heavy chain 7 (MYH7) to study the electrophysiology of HCM cardiomyocytes in electrically coupled syncytia, revealing significant conduction slowing and increased spatial dispersion of repolarisation - both well-established substrates for arrhythmia. Analysis of rhythmonome protein expression in MYH7 R403Q cardiomyocytes showed reduced expression of connexin-43 (also known as GJA1), sodium channels and inward rectifier potassium channels - a three-way hit that reduces electrotonic coupling and slows cardiac conduction. Our data represent a previously unreported, biophysical basis for arrhythmia in HCM that is intrinsic to cardiomyocyte electrophysiology. Later in the progression of the disease, these proarrhythmic phenotypes may be accentuated by myocyte disarray and fibrosis to contribute to sudden death.
The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy

Gabrielle Norrish,Cristian Topriceanu,Chen Qu,Ella Field,Helen Walsh,Lidia Ziółkowska,Iacopo Olivotto,Silvia Passantino,Silvia Favilli,Aris Anastasakis,Vasiliki Vlagkouli,Robert Weintraub,Ingrid King,Elena Biagini,Luca Ragni,Terrence Prendiville,Sophie Duignan,Karen McLeod,Maria Ilina,Adrian Fernández,Regina Bökenkamp,Anwar Baban,Fabrizio Drago,Peter Kubuš,Piers E F Daubeney,Sian Chivers,Georgia Sarquella-Brugada,Sergi Cesar,Chiara Marrone,Constancio Medrano,Reyes Alvarez Garcia-Roves,Orhan Uzun,Ferran Gran,Fernandez J Castro,Juan R Gimeno,Roberto Barriales-Villa,Fernando Rueda,Satish Adwani,Jonathan Searle,Tara Bharucha,Ana Siles,Ana Usano,Torsten B Rasmussen,Caroline B Jones,Toru Kubo,Jens Mogensen,Zdenka Reinhardt,Elena Cervi,Perry M Elliott,Rumana Z Omar,Juan P Kaski

DOI: https://doi.org/10.1093/eurjpc/zwab046

2022-03-30

Abstract:Aims: The 12-lead electrocardiogram (ECG) is routinely performed in children with hypertrophic cardiomyopathy (HCM). An ECG risk score has been suggested as a useful tool for risk stratification, but this has not been independently validated. This aim of this study was to describe the ECG phenotype of childhood HCM in a large, international, multi-centre cohort and investigate its role in risk prediction for arrhythmic events. Methods and results: Data from 356 childhood HCM patients with a mean age of 10.1 years (±4.5) were collected from a retrospective, multi-centre international cohort. Three hundred and forty-seven (97.5%) patients had ECG abnormalities at baseline, most commonly repolarization abnormalities (n = 277, 77.8%); left ventricular hypertrophy (n = 240, 67.7%); abnormal QRS axis (n = 126, 35.4%); or QT prolongation (n = 131, 36.8%). Over a median follow-up of 3.9 years (interquartile range 2.0-7.7), 25 (7%) had an arrhythmic event, with an overall annual event rate of 1.38 (95% CI 0.93-2.04). No ECG variables were associated with 5-year arrhythmic event on univariable or multivariable analysis. The ECG risk score threshold of >5 had modest discriminatory ability [C-index 0.60 (95% CI 0.484-0.715)], with corresponding negative and positive predictive values of 96.7% and 6.7. Conclusion: In a large, international, multi-centre cohort of childhood HCM, ECG abnormalities were common and varied. No ECG characteristic, either in isolation or combined in the previously described ECG risk score, was associated with 5-year sudden cardiac death risk. This suggests that the role of baseline ECG phenotype in improving risk stratification in childhood HCM is limited.
Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy(HCM-VAr-Risk Model)

Moumita Bhattacharya,Dai-Yin Lu,Shibani M Kudchadkar,Gabriela Villarreal Greenland,Prasanth Lingamaneni,Celia P Corona-Villalobos,Yufan Guan,Joseph E Marine,Jeffrey E Olgin,Stefan Zimmerman,Theodore P Abraham,Hagit Shatkay,Maria Roselle Abraham

DOI: https://doi.org/10.48550/arXiv.2109.09210

IF: 5.414

2021-09-19

Machine Learning

Abstract:Clinical risk stratification for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HC) employs rules derived from American College of Cardiology Foundation/American Heart Association (ACCF/AHA) guidelines or the HCM Risk-SCD model (C-index of 0.69), which utilize a few clinical variables. We assessed whether data-driven machine learning methods that consider a wider range of variables can effectively identify HC patients with ventricular arrhythmias (VAr) that lead to SCD. We scanned the electronic health records of 711 HC patients for sustained ventricular tachycardia or ventricular fibrillation. Patients with ventricular tachycardia or ventricular fibrillation (n = 61) were tagged as VAr cases and the remaining (n = 650) as non-VAr. The 2-sample t test and information gain criterion were used to identify the most informative clinical variables that distinguish VAr from non-VAr; patient records were reduced to include only these variables. Data imbalance stemming from low number of VAr cases was addressed by applying a combination of over- and under-sampling strategies.We trained and tested multiple classifiers under this sampling approach, showing effective classification. We evaluated 93 clinical variables, of which 22 proved predictive of VAr. The ensemble of logistic regression and naive Bayes classifiers, trained based on these 22 variables and corrected for data imbalance, was most effective in separating VAr from non-VAr cases (sensitivity = 0.73, specificity = 0.76, C-index = 0.83). Our method (HCM-VAr-Risk Model) identified 12 new predictors of VAr, in addition to 10 established SCD predictors. In conclusion, this is the first application of machine learning for identifying HC patients with VAr, using clinical attributes.
Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy: A Multicenter Cohort Study

Raymond H Chan,Laurine van der Wal,Gabriela Liberato,Ethan Rowin,Jonathan Soslow,Shiraz Maskatia,Sherwin Chan,Amee Shah,Mark Fogel,Lazaro Hernandez,Shafkat Anwar,Inga Voges,Marcus Carlsson,Sujatha Buddhe,Kai Thorsten Laser,Gerald Greil,Emanuela Valsangiacomo-Buechel,Iacopo Olivotto,Derek Wong,Cordula Wolf,Heynric Grotenhuis,Carsten Rickers,Kan Hor,Tobias Rutz,Shelby Kutty,Margaret Samyn,Tiffanie Johnson,Keren Hasbani,Jeremy P Moore,Ludger Sieverding,Jon Detterich,Rodrigo Parra,Paweena Chungsomprasong,Olga Toro-Salazar,Arno A W Roest,Sven Dittrich,Henrik Brun,Joseph Spinner,Wyman Lai,Adrian Dyer,Robert Jablonowsk,Christian Meierhofer,Dominik Gabbert,Milan Prsa,Jyoti Kandlikar Patel,Andreas Hornung,Simone Goa Diab,Aswathy Vaikom House,Harry Rakowski,Lee Benson,Martin S Maron,Lars Grosse-Wortmann

DOI: https://doi.org/10.1001/jamacardio.2024.2824

2024-11-01

Abstract:Importance: The ability to predict sudden cardiac death (SCD) in children and adolescents with hypertrophic cardiomyopathy (HCM) is currently inadequate. Late gadolinium enhancement (LGE) by cardiovascular magnetic resonance (CMR) imaging is associated with SCD events in adults with HCM. Objective: To examine the prognostic significance of LGE in patients with HCM who are younger than 21 years. Design, setting, and participants: This multicenter, retrospective cohort study was conducted from April 8, 2015, to September 12, 2022, in patients with HCM who were younger than 21 years and had undergone CMR imaging across multiple sites in the US, Europe, and South America. Observers of CMR studies were masked toward outcomes and demographic characteristics. Exposure: Natural history of HCM. Main outcome and measures: The primary outcome was SCD and surrogate events, including resuscitated cardiac arrest and appropriate discharges from an implantable defibrillator. Continuous and categorical data are expressed as mean (SD), median (IQR), or number (percentage), respectively. Survivor curves comparing patients with and without LGE were constructed by the Kaplan-Meier method, and likelihood of subsequent clinical events was further evaluated using univariate and multivariable Cox proportional hazards models. Results: Among 700 patients from 37 international centers, median (IQR) age was 14.8 (11.9-17.4) years, and 518 participants (74.0%) were male. During a median (IQR) [range] follow-up period of 1.9 (0.5-4.1) [0.1-14.8] years, 35 patients (5.0%) experienced SCD or equivalent events. LGE was present in 230 patients (32.9%), which constituted an mean (SD) burden of 5.9% (7.3%) of left ventricular myocardium. The LGE amount was higher in older patients and those with greater left ventricular mass and maximal wall thickness; patients with LGE had lower left ventricular ejection fractions and larger left atrial diameters. The presence and burden of LGE was associated with SCD, even after correcting for existing risk stratification tools. Patients with 10% or more LGE, relative to total myocardium, had a higher risk of SCD (unadjusted hazard ratio [HR], 2.19; 95% CI, 1.59-3.02; P < .001). Furthermore, the addition of LGE burden improved the performance of the HCM Risk-Kids score (before LGE addition: 0.66; 95% CI, 0.58-0.75; after LGE addition: 0.73; 95% CI, 0.66-0.81) and Precision Medicine in Cardiomyopathy score (before LGE addition: 0.68; 95% CI, 0.49-0.77; after LGE addition: 0.73; 95% CI, 0.64-0.82) SCD predictive models. Conclusions and relevance: In this retrospective cohort study, quantitative LGE was a risk factor for SCD in patients younger than 21 years with HCM and improved risk stratification.
Novel Magnetic Resonance Imaging Tools for Hypertrophic Cardiomyopathy Risk Stratification

Fahad Alajmi,Mehima Kang,James Dundas,Alexander Haenel,Jeremy Parker,Philipp Blanke,Fionn Coghlan,John King Khoo,Abdulaziz A. Bin Zaid,Amrit Singh,Bobby Heydari,Darwin Yeung,Thomas M. Roston,Kevin Ong,Jonathon Leipsic,Zachary Laksman

DOI: https://doi.org/10.3390/life14020200

2024-01-31

Life

Abstract:Hypertrophic cardiomyopathy (HCM) is a common genetic disorder with a well described risk of sudden cardiac death; however, risk stratification has remained a challenge. Recently, novel parameters in cardiac magnetic resonance imaging (CMR) have shown promise in helping to improve upon current risk stratification paradigms. In this manuscript, we have reviewed novel CMR risk markers and their utility in HCM. The results of the review showed that T1, extracellular volume, CMR feature tracking, and other miscellaneous novel CMR variables have the potential to improve sudden death risk stratification and may have additional roles in diagnosis and prognosis. The strengths and weaknesses of these imaging techniques, and their potential utility and implementation in HCM risk stratification are discussed.

biology
Identification of High-Risk Imaging Features in Hypertrophic Cardiomyopathy using Electrocardiography: A Deep-Learning Approach

Richard T. Carrick,Hisham Ahamed,Eric Sung,Martin S. Maron,Christopher Madias,Vennela Avula,Rachael Studley,Chen Bao,Nadia Bokhari,Erick Quintana,Ramiah Rajesh-kannan,Barry J. Maron,Katherine C. Wu,Ethan J. Rowin

DOI: https://doi.org/10.1016/j.hrthm.2024.01.031

IF: 6.779

2024-01-28

Heart Rhythm

Abstract:Background Patients with hypertrophic cardiomyopathy (HCM) are at risk for sudden death and individuals with ≥1 major risk markers are considered for primary prevention implantable cardioverter defibrillators. Guidelines recommend cardiac magnetic resonance imaging (CMR) to identify high-risk imaging features. However, CMR is resource intensive and is not widely accessible worldwide. Objective To develop electrocardiogram (ECG) deep-learning (DL) models for identification of HCM patients with high-risk features. Methods HCM patients evaluated at Tufts Medical Center (N=1,930; Boston, United States) were used to develop ECG-DL models for prediction of high-risk imaging features: systolic dysfunction, massive hypertrophy (≥30mm), apical aneurysm, and extensive late-gadolinium enhancement (LGE). ECG-DL models were externally validated in an HCM cohort from Amrita Hospital (N=233; Kochi, India). Results ECG-DL models reliably identified high-risk features (systolic dysfunction, massive hypertrophy, apical aneurysm, and extensive LGE) during hold-out model testing (c-statistics 0.72, 0.83, 0.93, and 0.76) and external validation (c-statistics 0.71, 0.76, 0.91, and 0.68). A hypothetical screening strategy employing echocardiography combined with ECG-DL guided selective CMR use demonstrated sensitivity of 97% for identifying patients with high-risk features, while reducing the number of recommended CMRs by 61%. Negative predictive value with this screening strategy for absence of high-risk features in patients without ECG-DL recommendation for CMR was 99.5%. Conclusions In HCM, novel ECG-DL models reliably identified patients with high-risk imaging features while offering the potential to reduce CMR testing requirements in under-resourced areas.

cardiac & cardiovascular systems
Diagnosis and management of arrhythmogenic cardiomyopathy: a case report

Jeremiah Haines,Noelle Garster,Divyanshu Mohananey,Maya S Safarova

DOI: https://doi.org/10.1093/ehjcr/ytae321

2024-07-18

Abstract:Background: Arrhythmogenic cardiomyopathy (ACM) is a genetically determined myocardial atrophy which progressively extends from the epicardium towards the endocardium, resulting in wall thinning. It is one of the leading causes of sudden death in young people. Postmortem studies demonstrate that up to 70-80% of the cases have biventricular involvement. Variable penetrance and expressivity results in a wide phenotypic spectrum, challenging diagnostic accuracy of advanced multimodality imaging tools. Prompt recognition, non-invasive imaging, risk stratification for sudden cardiac death (SCD), and preventive measures are paramount to improve prognosis. Case summary: Here, we present a 22-year-old Black male who was referred to our electrophysiology clinic with palpitations, remote syncope, and a family history of SCD. Over 3 years, he developed gradually worsening symptomatic palpitations. While physical exam and transthoracic echocardiography were unremarkable, his cardiac magnetic resonance imaging was consistent with biventricular ACM. Genetic testing confirmed ACM, revealing double heterozygosity in DSG2 and PKP2. Given the elevated estimated risk of life-threatening dysrhythmias, a subcutaneous cardiac defibrillator was successfully implanted. Discussion: Frequently, patients with ACM have more than one mutation in the same gene (compound heterozygosity) or in a second gene (double heterozygosity). Genetic counselling is strongly recommended for family members of the proband. The diagnosis of ACM may be mimicked by other diseases (cardiac sarcoidosis, dilated cardiomyopathy, amyloidosis), thus genetic testing can be useful to determine the presence of the disease. The present report provides an overview of the clinical course, diagnostic criteria, risk stratification, and prognostication for patients with ACM.
PREVALENCE AND RELATED FACTORS OF ARRHYTHMIAS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

Shulian Gu,Zhong Liu

DOI: https://doi.org/10.1136/heartjnl-2012-302920q.5

IF: 5.7

2012-01-01

Heart

Abstract:Objectives We aim to explore the incidence and risk factors of AF, dangerous ventricular arrhythmias and bradyarrhythmia in patients with HCM, and improve the awareness of clinicians on hypertrophic cardiomyopathy (HCM) associated with life-threatening arrhythmias. Methods We retrospectively collected the clinical data of 86 unrelated patients diagnosed as HCM in our hospital from January 2009 to January 2012, including each patient9s personal characteristics, clinical manifestations, echocardiography, 12-lead electrocardiography(ECG), 24 h Holter ECG monitoring, coronary angiography, left ventricular angiography and related treatment. Results 1. In 86 patients with HCM, male and female patients were 56 and 30, respectively, and mean age was 58.4±14.3 years. 2. 21 patients (24.4%) had documented AF, 7 patients with paroxysmal AF and 14 patients with chronic AF. 72 patients (85.7%) had premature ventricular contractions (PVCs), 36 patients (41.9%) had PVCs with Low grade ≥3, and 22 patients (25.6%) had non-sustained ventricular tachycardia (NSVT). eight patients (9.3%) had sick sinus syndrome (SSS), 11 patients (12.8%) had atrioventricular block (AVB) and nine patients (10.5%) had atrial fibrillation with slow ventricular rate and long RR interval (RR interval >2.0 s). 3. The mean age at examination was 64.1±11.0 years in patients with AF, older than those with sinus rhythm (56.6±14.8 years) (p=0.037). Left atrial diameter (LAD) was greater in patients with AF than those without AF (45.3±5.2 mm vs 40.2±5.2 mm) (p<0.01). There were 8 cases (38.1%) in NYHA classes III and IV in AF group, more than those without AF (6.2%, p=0.001). And left ventricular ejection fraction (LVEF) in AF group was lower than those without AF (64.8±9.7% vs 69.4±8.1%, p=0.036). 4. Maximum left ventricular wall thickness (MLVWT) and LAD was greater in patients with dangerous ventricular arrhythmias (B group) than in patients without dangerous ventricular arrhythmias (A group) (23.1±5.4 mm vs 20.2±4.9 mm and 42.8±5.2 mm vs 40.4±5.8 mm, p=0.009 and 0.048, respectively). The incidence of AF in B group was significantly higher than in A group (36.1% vs 16.0%, p<0.05). 5. In patients with pacemaker implantation, the age (mean 67.6±7.4 years) was older than those without pacemaker implantation (mean 55.5±14.1 years, p=0.01). LVEF in patients with pacemaker implantation was significantly lower than in patients without pacemaker implantation (64.0±10.0% vs 69.3±8.1%, p=0.024). And the incidence of AF in patients with pacemaker implantation was significantly higher than in patients without pacemaker implantation (52.9% vs 17.4%, p<0.05). Conclusions Our study showed the incidence of arrhythmias in patients with HCM, including AF, dangerous ventricular arrhythmias and bradyarrhythmia, was quite high. And the incidence of AF and bradyarrhythmia was positively correlated with age increasing. The occurrence of AF was significantly associated with LAD, cardiac dysfunction and age. The prevalence of dangerous ventricular arrhythmias was 41.9%, and its occurrence was associated with MLVWT and LAD. LVEF was significantly decreased in patients with pacemaker implantation. The prevalence of AF in patients with dangerous ventricular arrhythmias and bradyarrhythmia was much higher than others without dangerous ventricular arrhythmias and bradyarrhythmia. Therefore, AF might play an important role in the prognosis of HCM patients.
The dual role of carbenicillin in shoot regeneration and somatic embryogenesis of horseradish (Armoracia rusticana) in vitro

A. Shehata,W. Wannarat,R. Skirvin,M. Norton

DOI: https://doi.org/10.1007/s11240-010-9732-6

2010-03-26

Abstract:
Identical twins with ovarian endometriosis and mucinous borderline tumor: an unusual association.

M. Ko,Hun‐Shan Pan

DOI: https://doi.org/10.1016/j.fertnstert.2007.11.001

IF: 6.7

2008-10-01

Fertility and Sterility

Abstract:
Predictors of appropriate ICD discharges and the additive role of late gadolinium enhancement in hypertrophic cardiomyopathy

Srekar Ravi,Omar Baqal,Michael O'Shea,Olubadewa Fatunde,Jeffrey Geske,Konstantinos Siontis,Steve Ommen,Said Alsidawi

DOI: https://doi.org/10.1016/j.cardfail.2023.11.003

IF: 6.592

2024-01-04

Journal of Cardiac Failure

Abstract:Background Sudden cardiac death (SCD) is the most feared complications of hypertrophic cardiomyopathy (HCM). Indications for implantable cardioverter defibrillators (ICDs) in HCM patients are defined in the ACC/AHA guidelines. We sought to assess predictors of fatal arrythmias as defined by appropriate ICD discharges and the additive role of late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) to further assist in risk stratification. Methods Patients with HCM followed at a tertiary referral center who underwent CMR and ICD implantation between 2002-2022 were analyzed. Predictors of appropriate device shocks were assessed based on risk factors utilized by ACC/AHA guidelines. Univariable cox regression was used to quantify the association between baseline variables and shock rate. Bivariable cox regression with a term for interaction between presence of LGE >10% and ICD indication was then conducted. Results 134 patients with left ventricular ejection fraction >50% were included, of whom 114 had available LGE quantification on CMR. Median follow up time was 3.7 years. The strongest predictor of receiving appropriate ICD shock was an ICD placement as secondary prevention (10 patients) [HR 8.64 (3.48 to 21.48)]. The primary prevention indication most strongly associated with early ICD shock was presence of ventricular arrythmias on ambulatory monitoring [HR 2.03 (0.91 to 4.57)] (Table 1). Female sex was protective (HR: 0.21). This study did not find an increased risk of appropriate ICD discharge for primary prevention indications including syncope, family history of SCD, or massive hypertrophy, possibly related to sample size and follow-up duration. However, examination of stratum specific rates strongly supports effect modification by LGE. There was strong evidence for an exponential synergistic interaction between LGE burden >10% and both syncope (interaction term 5.5) and apical pouch/aneurysm (interaction term 4.63) (Table 2). Conclusions SCD risk stratification and ICD implantation decision-making remains complex in HCM. Recognizing the synergistic effects of LGE on traditional risk factors for appropriate ICD discharge may enhance clinical judgment for ICD implantation. Further studies are needed to assess how LGE noted on CMR and other primary prevention indications for an ICD in HCM patients might interact.

cardiac & cardiovascular systems

Epidemien und Pandemien in der hausärztlichen Praxis

Electromechanical Relationship in Hypertrophic Cardiomyopathy

Abstract 58: Modeling Pathogenesis in Familial Hypertrophic Cardiomyopathy Using Patient-Specific Induced Pluripotent Stem Cells

Electrophysiological Characterization of Subclinical and Overt Hypertrophic Cardiomyopathy by Magnetic Resonance Imaging-Guided Electrocardiography

Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in Patient-Specific Induced Pluripotent Stem Cells.

Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study

Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial, electrophysiology study inclusive approach

Changing management of gallstone disease during pregnancy

Hypersynchrony in sarcomeric hypertrophic cardiomyopathy: description and mechanistic approach using multimodal electro-mechanical non-invasive cartography (HSYNC study)

Novel electric predictors of lethal arrhythmic event in patients with hypertrophic cardiomyopathy

Reduced connexin-43 expression, slow conduction and repolarisation dispersion in a model of hypertrophic cardiomyopathy

The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy

Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy(HCM-VAr-Risk Model)

Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy: A Multicenter Cohort Study

Novel Magnetic Resonance Imaging Tools for Hypertrophic Cardiomyopathy Risk Stratification

Identification of High-Risk Imaging Features in Hypertrophic Cardiomyopathy using Electrocardiography: A Deep-Learning Approach

Diagnosis and management of arrhythmogenic cardiomyopathy: a case report

PREVALENCE AND RELATED FACTORS OF ARRHYTHMIAS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

The dual role of carbenicillin in shoot regeneration and somatic embryogenesis of horseradish (Armoracia rusticana) in vitro

Identical twins with ovarian endometriosis and mucinous borderline tumor: an unusual association.

Predictors of appropriate ICD discharges and the additive role of late gadolinium enhancement in hypertrophic cardiomyopathy